IQVIA HOLDINGS INC (IQV) Stock Fundamental Analysis

NYSE:IQV • US46266C1053

174.27 USD
-4.54 (-2.54%)
At close: Mar 2, 2026
174.27 USD
0 (0%)
After Hours: 3/2/2026, 7:28:36 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to IQV. IQV was compared to 57 industry peers in the Life Sciences Tools & Services industry. IQV scores excellent on profitability, but there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on IQV.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • IQV had positive earnings in the past year.
  • IQV had a positive operating cash flow in the past year.
  • In the past 5 years IQV has always been profitable.
  • Each year in the past 5 years IQV had a positive operating cash flow.
IQV Yearly Net Income VS EBIT VS OCF VS FCFIQV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

  • IQV has a Return On Assets of 4.54%. This is amongst the best in the industry. IQV outperforms 80.70% of its industry peers.
  • IQV has a better Return On Equity (20.91%) than 92.98% of its industry peers.
  • With an excellent Return On Invested Capital value of 8.79%, IQV belongs to the best of the industry, outperforming 85.96% of the companies in the same industry.
  • IQV had an Average Return On Invested Capital over the past 3 years of 8.91%. This is below the industry average of 11.60%.
Industry RankSector Rank
ROA 4.54%
ROE 20.91%
ROIC 8.79%
ROA(3y)4.91%
ROA(5y)4.59%
ROE(3y)21.92%
ROE(5y)20.14%
ROIC(3y)8.91%
ROIC(5y)8.09%
IQV Yearly ROA, ROE, ROICIQV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • With a decent Profit Margin value of 8.34%, IQV is doing good in the industry, outperforming 78.95% of the companies in the same industry.
  • IQV's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 14.02%, IQV is in the better half of the industry, outperforming 77.19% of the companies in the same industry.
  • In the last couple of years the Operating Margin of IQV has grown nicely.
  • IQV's Gross Margin of 33.29% is on the low side compared to the rest of the industry. IQV is outperformed by 64.91% of its industry peers.
  • IQV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.02%
PM (TTM) 8.34%
GM 33.29%
OM growth 3Y3.41%
OM growth 5Y15.26%
PM growth 3Y3.27%
PM growth 5Y27.69%
GM growth 3Y-1.55%
GM growth 5Y-0.4%
IQV Yearly Profit, Operating, Gross MarginsIQV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • IQV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, IQV has less shares outstanding
  • The number of shares outstanding for IQV has been reduced compared to 5 years ago.
  • Compared to 1 year ago, IQV has a worse debt to assets ratio.
IQV Yearly Shares OutstandingIQV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
IQV Yearly Total Debt VS Total AssetsIQV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • IQV has an Altman-Z score of 1.84. This is not the best score and indicates that IQV is in the grey zone with still only limited risk for bankruptcy at the moment.
  • IQV's Altman-Z score of 1.84 is fine compared to the rest of the industry. IQV outperforms 61.40% of its industry peers.
  • The Debt to FCF ratio of IQV is 7.67, which is on the high side as it means it would take IQV, 7.67 years of fcf income to pay off all of its debts.
  • IQV's Debt to FCF ratio of 7.67 is fine compared to the rest of the industry. IQV outperforms 63.16% of its industry peers.
  • IQV has a Debt/Equity ratio of 2.14. This is a high value indicating a heavy dependency on external financing.
  • IQV has a worse Debt to Equity ratio (2.14) than 85.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.14
Debt/FCF 7.67
Altman-Z 1.84
ROIC/WACC0.86
WACC10.2%
IQV Yearly LT Debt VS Equity VS FCFIQV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.3 Liquidity

  • IQV has a Current Ratio of 0.75. This is a bad value and indicates that IQV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • IQV has a Current ratio of 0.75. This is amonst the worse of the industry: IQV underperforms 91.23% of its industry peers.
  • IQV has a Quick Ratio of 0.75. This is a bad value and indicates that IQV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • IQV's Quick ratio of 0.75 is on the low side compared to the rest of the industry. IQV is outperformed by 89.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
IQV Yearly Current Assets VS Current LiabilitesIQV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • IQV shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.09%.
  • The Earnings Per Share has been growing by 13.19% on average over the past years. This is quite good.
  • Looking at the last year, IQV shows a small growth in Revenue. The Revenue has grown by 5.87% in the last year.
  • IQV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.50% yearly.
EPS 1Y (TTM)7.09%
EPS 3Y5.46%
EPS 5Y13.19%
EPS Q2Q%9.62%
Revenue 1Y (TTM)5.87%
Revenue growth 3Y4.21%
Revenue growth 5Y7.5%
Sales Q2Q%10.26%

3.2 Future

  • IQV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.90% yearly.
  • IQV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.52% yearly.
EPS Next Y9.67%
EPS Next 2Y10.17%
EPS Next 3Y10.4%
EPS Next 5Y10.9%
Revenue Next Year6.51%
Revenue Next 2Y6.21%
Revenue Next 3Y6.27%
Revenue Next 5Y6.52%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
IQV Yearly Revenue VS EstimatesIQV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
IQV Yearly EPS VS EstimatesIQV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.61, the valuation of IQV can be described as correct.
  • Based on the Price/Earnings ratio, IQV is valued cheaply inside the industry as 94.74% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.13. IQV is valued slightly cheaper when compared to this.
  • IQV is valuated correctly with a Price/Forward Earnings ratio of 13.32.
  • 92.98% of the companies in the same industry are more expensive than IQV, based on the Price/Forward Earnings ratio.
  • IQV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.11.
Industry RankSector Rank
PE 14.61
Fwd PE 13.32
IQV Price Earnings VS Forward Price EarningsIQV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IQV is valued cheaply inside the industry as 91.23% of the companies are valued more expensively.
  • IQV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IQV is cheaper than 89.47% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.41
EV/EBITDA 12.75
IQV Per share dataIQV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50

4.3 Compensation for Growth

  • IQV's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of IQV may justify a higher PE ratio.
PEG (NY)1.51
PEG (5Y)1.11
EPS Next 2Y10.17%
EPS Next 3Y10.4%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for IQV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IQVIA HOLDINGS INC

NYSE:IQV (3/2/2026, 7:28:36 PM)

After market: 174.27 0 (0%)

174.27

-4.54 (-2.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05
Earnings (Next)05-04
Inst Owners100.57%
Inst Owner Change0.64%
Ins Owners0.86%
Ins Owner Change2.51%
Market Cap29.56B
Revenue(TTM)16.31B
Net Income(TTM)1.36B
Analysts82.67
Price Target244.68 (40.4%)
Short Float %2.72%
Short Ratio2.54
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.19%
Min EPS beat(2)-0.33%
Max EPS beat(2)-0.04%
EPS beat(4)2
Avg EPS beat(4)0.41%
Min EPS beat(4)-0.33%
Max EPS beat(4)1.56%
EPS beat(8)5
Avg EPS beat(8)0.54%
EPS beat(12)8
Avg EPS beat(12)0.59%
EPS beat(16)11
Avg EPS beat(16)0.76%
Revenue beat(2)1
Avg Revenue beat(2)0.75%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)1.91%
Revenue beat(4)3
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-0.41%
Max Revenue beat(4)1.91%
Revenue beat(8)3
Avg Revenue beat(8)0.19%
Revenue beat(12)5
Avg Revenue beat(12)0%
Revenue beat(16)6
Avg Revenue beat(16)-0.05%
PT rev (1m)-6.55%
PT rev (3m)-2.95%
EPS NQ rev (1m)-4.18%
EPS NQ rev (3m)-3.94%
EPS NY rev (1m)0.04%
EPS NY rev (3m)0.29%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)0.56%
Revenue NY rev (1m)1.01%
Revenue NY rev (3m)1.17%
Valuation
Industry RankSector Rank
PE 14.61
Fwd PE 13.32
P/S 1.81
P/FCF 14.41
P/OCF 11.14
P/B 4.55
P/tB N/A
EV/EBITDA 12.75
EPS(TTM)11.93
EY6.85%
EPS(NY)13.08
Fwd EY7.51%
FCF(TTM)12.09
FCFY6.94%
OCF(TTM)15.65
OCFY8.98%
SpS96.17
BVpS38.34
TBVpS-88.89
PEG (NY)1.51
PEG (5Y)1.11
Graham Number101.45
Profitability
Industry RankSector Rank
ROA 4.54%
ROE 20.91%
ROCE 10.59%
ROIC 8.79%
ROICexc 9.76%
ROICexgc N/A
OM 14.02%
PM (TTM) 8.34%
GM 33.29%
FCFM 12.58%
ROA(3y)4.91%
ROA(5y)4.59%
ROE(3y)21.92%
ROE(5y)20.14%
ROIC(3y)8.91%
ROIC(5y)8.09%
ROICexc(3y)9.78%
ROICexc(5y)8.82%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.72%
ROCE(5y)9.74%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.87%
ROICexc growth 5Y22.13%
OM growth 3Y3.41%
OM growth 5Y15.26%
PM growth 3Y3.27%
PM growth 5Y27.69%
GM growth 3Y-1.55%
GM growth 5Y-0.4%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 2.14
Debt/FCF 7.67
Debt/EBITDA 4.05
Cap/Depr 52.71%
Cap/Sales 3.7%
Interest Coverage 3.53
Cash Conversion 77.35%
Profit Quality 150.81%
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 1.84
F-Score5
WACC10.2%
ROIC/WACC0.86
Cap/Depr(3y)54.81%
Cap/Depr(5y)54.94%
Cap/Sales(3y)3.98%
Cap/Sales(5y)4.25%
Profit Quality(3y)138.41%
Profit Quality(5y)159.78%
High Growth Momentum
Growth
EPS 1Y (TTM)7.09%
EPS 3Y5.46%
EPS 5Y13.19%
EPS Q2Q%9.62%
EPS Next Y9.67%
EPS Next 2Y10.17%
EPS Next 3Y10.4%
EPS Next 5Y10.9%
Revenue 1Y (TTM)5.87%
Revenue growth 3Y4.21%
Revenue growth 5Y7.5%
Sales Q2Q%10.26%
Revenue Next Year6.51%
Revenue Next 2Y6.21%
Revenue Next 3Y6.27%
Revenue Next 5Y6.52%
EBIT growth 1Y0.79%
EBIT growth 3Y7.77%
EBIT growth 5Y23.91%
EBIT Next Year27.15%
EBIT Next 3Y13%
EBIT Next 5Y11.38%
FCF growth 1Y-2.98%
FCF growth 3Y8.95%
FCF growth 5Y8.84%
OCF growth 1Y-2.28%
OCF growth 3Y5.5%
OCF growth 5Y6.26%

IQVIA HOLDINGS INC / IQV FAQ

Can you provide the ChartMill fundamental rating for IQVIA HOLDINGS INC?

ChartMill assigns a fundamental rating of 5 / 10 to IQV.


Can you provide the valuation status for IQVIA HOLDINGS INC?

ChartMill assigns a valuation rating of 7 / 10 to IQVIA HOLDINGS INC (IQV). This can be considered as Undervalued.


Can you provide the profitability details for IQVIA HOLDINGS INC?

IQVIA HOLDINGS INC (IQV) has a profitability rating of 7 / 10.


What are the PE and PB ratios of IQVIA HOLDINGS INC (IQV) stock?

The Price/Earnings (PE) ratio for IQVIA HOLDINGS INC (IQV) is 14.61 and the Price/Book (PB) ratio is 4.55.


Can you provide the financial health for IQV stock?

The financial health rating of IQVIA HOLDINGS INC (IQV) is 3 / 10.